Morgan Stanley
VMD icon

Morgan Stanley’s Viemed Healthcare VMD Stock Holding History

Morgan Stanley’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
300,410
-24,128
-7% -$239K ﹤0.01% 4485
2026
Q1 		$2.99M Buy
324,538
+31,767
+11% +$264K ﹤0.01% 4473
2025
Q4 		$2.18M Buy
292,771
+27,206
+10% +$186K ﹤0.01% 4747
2025
Q3 		$1.8M Sell
265,565
-19,731
-7% -$134K ﹤0.01% 4855
2025
Q2 		$1.97M Buy
285,296
+114,718
+67% +$779K ﹤0.01% 4714
2025
Q1 		$1.24M Buy
170,578
+40,655
+31% +$319K ﹤0.01% 4903
2024
Q4 		$1.04M Sell
129,923
-14,040
-10% -$122K ﹤0.01% 5068
2024
Q3 		$1.06M Sell
143,963
-125,554
-47% -$897K ﹤0.01% 5015
2024
Q2 		$1.77M Sell
269,517
-44,951
-14% -$339K ﹤0.01% 4642
2024
Q1 		$2.97M Sell
314,468
-312,944
-50% -$2.68M ﹤0.01% 4332
2023
Q4 		$4.93M Buy
627,412
+337,589
+116% +$2.45M ﹤0.01% 4386
2023
Q3 		$1.95M Sell
289,823
-26,619
-8% -$218K ﹤0.01% 4411
2023
Q2 		$3.09M Sell
316,442
-16,693
-5% -$170K ﹤0.01% 4124
2023
Q1 		$3.22M Buy
333,135
+53,700
+19% +$468K ﹤0.01% 4130
2022
Q4 		$2.11M Sell
279,435
-12,492
-4% -$84.6K ﹤0.01% 4426
2022
Q3 		$1.75M Buy
291,927
+115,619
+66% +$742K ﹤0.01% 4528
2022
Q2 		$948K Buy
176,308
+158,426
+886% +$854K ﹤0.01% 5042
2022
Q1 		$88K Sell
17,882
-5,930
-25% -$27.5K ﹤0.01% 6389
2021
Q4 		$125K Sell
23,812
-12,375
-34% -$69.1K ﹤0.01% 6310
2021
Q3 		$202K Sell
36,187
-80,073
-69% -$521K ﹤0.01% 5996
2021
Q2 		$831K Buy
116,260
+52,243
+82% +$452K ﹤0.01% 5196
2021
Q1 		$648K Sell
64,017
-29,145
-31% -$274K ﹤0.01% 5011
2020
Q4 		$723K Sell
93,162
-3,419
-4% -$30.1K ﹤0.01% 4848
2020
Q3 		$833K Buy
96,581
+20,450
+27% +$206K ﹤0.01% 4338
2020
Q2 		$731K Buy
+76,131
New +$592K ﹤0.01% 4390
2020
Q1 		– Sell
-264,348
Closed -$1.64M – 6716
2019
Q4 		$1.64M Sell
264,348
-18,603
-7% -$129K ﹤0.01% 4189
2019
Q3 		$1.96M Buy
+282,951
New +$1.89M ﹤0.01% 3812

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Morgan Stanley's VMD Position: Q2 2026 in Review

Morgan Stanley reduced its Viemed Healthcare (VMD) stake by 7.4% in Q2 2026, selling an estimated $239K and leaving 300,410 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4485.

Morgan Stanley first reported a position in VMD in Q3 2019 and has held it in 27 quarters since. The position peaked at $4.93M in Q4 2023. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Morgan Stanley held 300,410 shares of Viemed Healthcare worth $3.42M as of Q2 2026.
  • Morgan Stanley sold 24,128 Viemed Healthcare shares in Q2 2026, an estimated $239K.
  • Viemed Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4485 holding.
  • Morgan Stanley first reported a position in Viemed Healthcare in Q3 2019 and has held it in 27 quarters since.
  • Morgan Stanley's Viemed Healthcare position peaked at $4.93M in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.